bisindolylmaleimide i has been researched along with Osteosarcoma in 1 studies
bisindolylmaleimide I: a bis(indolyl)maleimide
Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, ST | 1 |
| Cheng, HH | 1 |
| Huang, CJ | 1 |
| Chang, HC | 1 |
| Chi, CC | 1 |
| Su, HH | 1 |
| Hsu, SS | 1 |
| Wang, JL | 1 |
| Chen, IS | 1 |
| Liu, SI | 1 |
| Lu, YC | 1 |
| Huang, JK | 1 |
| Ho, CM | 1 |
| Jan, CR | 1 |
1 other study available for bisindolylmaleimide i and Osteosarcoma
| Article | Year |
|---|---|
Phospholipase A2-independent Ca2+ entry and subsequent apoptosis induced by melittin in human MG63 osteosarcoma cells.
Topics: Apoptosis; Calcium; Calcium Channels, L-Type; Cell Line, Tumor; Cell Survival; Egtazic Acid; Enzyme | 2007 |